Votrient 200 mg. Tablet
Votrient 200mg Tablet is used to treat kidney cancer and its associated symptoms such as blood in the urine, unexplained low back pain or weight loss, fatigue, loss of appetite, etc. It stops cancer growth and prevents multiplication of cancer cells. This restricts the advancement of cancer to other unaffected regions
Related products
-
Vymada 100 mg Tablet
0 out of 5(0)Vymada 100mg Tablet is a combination of two medicines: Sacubitril and Valsartan which belong to a class of angiotensin receptor neprilysin inhibitor (ARNI). This combination treats heart failure by relaxing the blood vessels and making it easier for your heart to pump blood throughout your body.
Login To See PriceCompare -
AF 400 Tablet
0 out of 5(0)AF 400 Tablet is an anti-fungal medicine. It is used for the treatment of many fungal infections like Cryptococcal meningitis (fungal infection in the brain) and Coccidioidomycosis (a disease of the lungs)
Login To See PriceCompare -
Afinitor Tablet
0 out of 5(0)Everolimus is a targeted cancer drug that blocks cancer growth, its also known by its brand name Afinitor. You might have everolimus if you have advanced: breast cancer that is hormone receptor positive.
Login To See PriceCompare -
Lenangio 25 mg Tablet
0 out of 5(0)Lenangio 25mg Capsule is an anti-cancer medication. It works by enhancing the immune system that indirectly attacks the cancer cells. It prevents the growth of new blood vessels within the tumor.
Login To See PriceCompare -
Theo-Asthalin Forte Tablet
0 out of 5(0)Theo-Asthalin Forte Tablet is a combination medicine used in the treatment of asthma. It helps in relaxing the muscles of the air passages, thus widening it and making it easier to breathe
Login To See PriceCompare -
Crizalk 250 mg Tablet
0 out of 5(0)Crizalk 250mg Capsule is an anti-cancer medication. It works by blocking the action of the abnormal protein that signals cancer cells to multiply. This helps to stop or slow the spread of cancer cells.
Login To See PriceCompare
Reviews
There are no reviews yet.